Merck (NYSE:MRK) stock is up 5% to trade at $121.75, after the blue-chip pharma giant received the "go ahead" from European ...

Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its blockbuster cancer drug ...

Rahway-based pharma giant Merck plans to spend $6.7 billion to purchase Terns Pharmaceuticals in an effort to boost its hematology pipeline. As part of the deal, Merck gains access to an experimental ...

Merck & Co. Inc. MRK is nearing an all-cash deal to acquire Terns Pharmaceuticals, Inc. TERN for roughly $6 billion, aiming to strengthen its oncology pipeline ahead of Keytruda losing U.S. patent ...

March 24 (Reuters) - Pharmaceutical company Merck (MRK.N), opens new tab is nearing a roughly $6 billion ‌all-cash deal to acquire biotech firm Terns Pharma (TERN.O), opens new tab, the Financial ...

Merck will acquire Terns for $53 per share in cash, amounting to an equity value of about $6.7 billion. This is the third multibillion-dollar acquisition for Merck over the past year as it looks to ...

Merck MRK1.49%increase; green up pointing triangle & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the drugmaker’s respiratory portfolio ...